Trial Profile
Efficacy study of CT 7001
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 05 Dec 2017
Price :
$35
*
At a glance
- Drugs Samuraciclib (Primary)
- Indications Acute myeloid leukaemia; Breast cancer; Cancer; Small cell lung cancer
- Focus Therapeutic Use
- 05 Dec 2017 New trial record
- 30 Nov 2017 According to a Carrick Therapeutics media release,this trial is planned in 2018.